RU2018132631A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2018132631A3 RU2018132631A3 RU2018132631A RU2018132631A RU2018132631A3 RU 2018132631 A3 RU2018132631 A3 RU 2018132631A3 RU 2018132631 A RU2018132631 A RU 2018132631A RU 2018132631 A RU2018132631 A RU 2018132631A RU 2018132631 A3 RU2018132631 A3 RU 2018132631A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662295545P | 2016-02-16 | 2016-02-16 | |
| US62/295,545 | 2016-02-16 | ||
| PCT/IB2017/000194 WO2017141106A1 (en) | 2016-02-16 | 2017-02-16 | Veldoreotide with poor solubitliy in physiological conditions for use in the treatment of acromegaly, acromegaly cancer, sst-r5 expressing tumors, type 2 diabetes, hyperglycemia, and hormone-related tumors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2018132631A RU2018132631A (ru) | 2020-03-17 |
| RU2018132631A3 true RU2018132631A3 (ru) | 2020-05-13 |
| RU2736590C2 RU2736590C2 (ru) | 2020-11-18 |
Family
ID=58448573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018132631A RU2736590C2 (ru) | 2016-02-16 | 2017-02-16 | Велдореотид, обладающий плохой растворимостью в физиологических условиях, для применения при лечении акромегалии, акромегалии со злокачественным новообразованием, экспрессирующих sst-r5 опухолей, диабета 2 типа, гипергликемии и опухолей, связанных с гормонами |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP3416666B1 (ru) |
| JP (1) | JP7030720B2 (ru) |
| CN (1) | CN109462982A (ru) |
| AU (1) | AU2017220728A1 (ru) |
| BR (1) | BR112018016774A2 (ru) |
| CA (1) | CA3014406A1 (ru) |
| ES (1) | ES2906791T3 (ru) |
| RU (1) | RU2736590C2 (ru) |
| WO (1) | WO2017141106A1 (ru) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235886A (en) | 1979-10-31 | 1980-11-25 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
| US4310518A (en) | 1979-10-31 | 1982-01-12 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
| US6051554A (en) * | 1995-06-07 | 2000-04-18 | Peptor Limited | Conformationally constrained backbone cyclized somatostatin analogs |
| US6355613B1 (en) | 1996-07-31 | 2002-03-12 | Peptor Limited | Conformationally constrained backbone cyclized somatostatin analogs |
| EP0880969A1 (en) | 1997-05-28 | 1998-12-02 | Applied Research Systems ARS Holdings N.V. | Pharmaceutical compositions of peptides having low solubility in physiological medium |
| JP2006516642A (ja) | 2003-02-03 | 2006-07-06 | シャイア ラボラトリーズ，インコーポレイテッド | 薬物製剤およびメチル化シクロデキストリン結晶を用いた送達 |
| AP2007004067A0 (en) * | 2005-02-22 | 2007-08-31 | Pfizer | Oxyindole derivatives as 5HT4 receptor agonists |
| EP2350118B1 (en) | 2008-09-19 | 2016-03-30 | Nektar Therapeutics | Carbohydrate-based drug delivery polymers and conjugates thereof |
| US20100086597A1 (en) * | 2008-10-06 | 2010-04-08 | Oakwood Laboratories LLC | Microspheres for the sustained release of octreotide with a low initial burst |
| EP2461800A2 (en) * | 2009-08-05 | 2012-06-13 | Pieris AG | Controlled release formulations of lipocalin muteins |
| WO2011087496A1 (en) * | 2010-01-13 | 2011-07-21 | Oakwood Laboratories LLC | Microspheres for the sustained release of octreotide without an initial time lag |
| CN111249255A (zh) * | 2020-03-04 | 2020-06-09 | 烟台大学 | 温敏水凝胶载药的新型微球复合制剂及制备方法 |
-
2017
- 2017-02-16 CA CA3014406A patent/CA3014406A1/en active Pending
- 2017-02-16 WO PCT/IB2017/000194 patent/WO2017141106A1/en active Application Filing
- 2017-02-16 BR BR112018016774-6A patent/BR112018016774A2/pt not_active IP Right Cessation
- 2017-02-16 RU RU2018132631A patent/RU2736590C2/ru active
- 2017-02-16 CN CN201780023841.6A patent/CN109462982A/zh active Pending
- 2017-02-16 JP JP2018561098A patent/JP7030720B2/ja active Active
- 2017-02-16 AU AU2017220728A patent/AU2017220728A1/en not_active Abandoned
- 2017-02-16 EP EP17714266.8A patent/EP3416666B1/en not_active Not-in-force
- 2017-02-16 ES ES17714266T patent/ES2906791T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017220728A1 (en) | 2018-08-23 |
| CA3014406A1 (en) | 2017-08-24 |
| JP7030720B2 (ja) | 2022-03-07 |
| EP3416666A1 (en) | 2018-12-26 |
| JP2019504897A (ja) | 2019-02-21 |
| RU2018132631A (ru) | 2020-03-17 |
| RU2736590C2 (ru) | 2020-11-18 |
| ES2906791T3 (es) | 2022-04-20 |
| EP3416666B1 (en) | 2021-10-27 |
| BR112018016774A2 (pt) | 2018-12-26 |
| CN109462982A (zh) | 2019-03-12 |
| WO2017141106A1 (en) | 2017-08-24 |